Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Supply chain

Network set up to study drug shortages across Europe

The European Union has launched a European Medicines Shortages Research Network to look at the causes of medicines shortages and their impact on patients.

Eighteen EU countries have signed up so far to the four-year programme, an initiative of the European Cooperation in Science and Technology (CoST), which supports cooperation among researchers across Europe. More are expected to join and non-EU countries are able to attend meetings as observers.

The research network will explore the reasons for drug shortages in both primary and secondary care, including whether countries face similar or different issues, and it will then make recommendations on how medicines shortages can be prevented or minimised. The ultimate aim is to develop a set of principles that can be adopted across the EU.

Working groups have been set up to address a number of areas: the landscape of medicines shortages; manufacturing-related shortages; logistics-related shortages; therapeutic options and substitutions; and the impact of shortages on outcomes.

David Stead, former specialist procurement pharmacist at NHS South West, is chairing the logistics working group, supported by another UK representative Jane Nicholson, executive director of the European Industrial Pharmacists Group.

Stead said European countries procure medicines in different ways, so the initial focus will be on understanding the mechanisms in each country, so “we can identify whether the way that medicines are provided and procured actually creates problems”. Then the group will look at evidence based practice to make recommendations on how to prevent or minimise distribution problems and improve the clinical management of shortages.

The network is chaired by Helena Jenzer from the University of Bern, Switzerland, with Roberto Frontini, president of the European Association of Hospital Pharmacists (EAHP), as deputy chair.

 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201074

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Close up of drug production line

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.